← Back to headlines
SpyGlass Pharma Reports GAAP EPS of -$5.72
SpyGlass Pharma, Inc. has released its financial results, reporting a GAAP Earnings Per Share of -$5.72.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
South Korean Retail Investors Exit Leveraged Semiconductor ETFs
31m ago
HDFC Bank CEO Sashidhar Jagdishan to Step Down in October
3h ago
FSSAI Bans Everest and Laljee Godhoo From Selling Substandard Hing Powder
4h ago
UAE Central Bank Launches Probe Into Banque Misr Over US Money Laundering Warnings
4h ago